Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 204INDUSTRY 55NIH 24NETWORK 6OTHER_GOV 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 3Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thoracic Neoplasms 1Sarcopenia 1Recurrence 1Rectal Neoplasms 1Rare Diseases 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurologic Manifestations 1Neoplasms by Site 1Neoplasm Metastasis 1Myasthenia Gravis 1Mental Disorders 1Lung Neoplasms 1Lung Diseases 1Liver Neoplasms 1Head and Neck Neoplasms 1Early Stage Lung Cancer (I and II) 1Condylomata Acuminata 1Colonic Polyps 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Bronchogenic 1Cachexia 1Breast Neoplasms 1Anxiety Disorders 1Adenomatous Polyposis Coli 1

Interventions

Midazolam 1Ketamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × FED × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Clear all
NCT03043430 2023-04-25

Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients

Brooke Army Medical Center

Phase 4 Terminated
10 enrolled
LymphoidOther hematologic neoplasm

Anxiety Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡